Massive study reveals best diabetes drugs for your heart

NCT ID NCT05073692

Completed Knowledge-focused Sponsor: Kaiser Permanente Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at nearly 242,000 adults with type 2 diabetes to compare different glucose-lowering medications and their effects on heart health. The goal was to help patients and doctors choose the best treatment based on age, sex, race, and kidney function. The main focus was on major heart problems like heart attacks and strokes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOVASCULAR DISEASES TYPE 2 DIABETES MELLITUS

Contacts and locations

Locations

Geisinger

Danville, Pennsylvania, 17821, United States
HealthPartners Institute

Bloomington, Minnesota, 55425, United States
Henry Ford Health System

Detroit, Michigan, 48202, United States
Kaiser Permanente Hawaii

Honolulu, Hawaii, 96817, United States
Kaiser Permanente Southern California

Pasadena, California, 91101, United States
Romain S. Neugebauer

Pleasanton, California, 94588, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.